# Automated Medication Dispensing Cabinet Market

> Automated Medication Dispensing Cabinet Market: USD 2.33 billion in 2025, 6.08% CAGR to 2035 as a 418,000-unit ward fleet enters replacement.

Publisher: Douglas Insights  
Author: Douglas Insights Research Desk  
Report code: DI-HC-10491  
Published: 2026-10-07  
Last updated: 2026-10-07  
Next review: Apr 2027  
Page: https://www.douglasinsights.com/automated-medication-dispensing-cabinet-market/

## Key figures

| Measure | Value | How it is built |
| --- | --- | --- |
| Market size · 2025 | $2.33 Bn | 52,600 cabinet-equivalents x USD 44,300 = USD 2.33 billion |
| Forecast · 2035 | $4.20 Bn | USD 4.20 billion at 6.08% a year |
| Revenue CAGR · 2026–2035 | 6.08% | Replacement 1.7, non-acute 1.3, workflow 1.1 points |
| Volume · 2035 | 78,613 cabinets | 52,600 shipments in 2025 growing 4.1% a year |
| Leading segment | Main drawer cabinets, 46.7% | USD 1.09 billion in 2025 |
| Fastest segment | Countertop and anaesthesia workstations, 8.69% | Surgery centres and long-term care |
| Fastest region | Asia Pacific, 8.46% | Greenfield tertiary hospitals |
| Market leader | BD, 49.1% est. | Douglas Insights estimate from BD medication management revenue of USD 3.47 billion |
| Event | Pyxis firmware recall, 20 Nov 2025 | FDA Class 2 recall covering 53,669 units |

## Key takeaways

- Douglas Insights sizes the market at USD 2.33 billion in 2025 from 52,600 cabinet-equivalents at USD 44,300.
- Revenue reaches USD 4.20 billion by 2035, growing 6.08% a year from 4.1% volume and 1.9% price.
- Replacement of a 418,000-unit installed base supplies 1.7 of the 4.1 volume points.
- BD holds an estimated 49.1% share and the top three suppliers 72.2%.
- Asia Pacific grows fastest at 8.46%, while North America keeps USD 1.22 billion of 2025 revenue.

53,669 BD Pyxis cabinets and safes were in US commerce when CareFusion 303 opened a firmware recall on 20 November 2025, according to the [FDA recall database entry](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=216381), a single counted fleet that shows how deep the Automated Medication Dispensing Cabinet Market already runs. Automated medication dispensing cabinets are locked, software-controlled drawer and bin units on hospital wards that release a dose only to an authorised nurse against a pharmacist-verified order; the market covers new cabinet systems, their bundled software and installation. Douglas Insights estimates 52,600 cabinet-equivalent shipments in 2025 at an average realised USD 44,300 each, which multiplies to USD 2.33 billion, rising to USD 4.20 billion in 2035 at a revenue CAGR of 6.08%. The study belongs to our [hospital infrastructure](https://www.douglasinsights.com/industry/healthcare/hospital-infrastructure/) research and uses the [Douglas Insights research methodology](https://www.douglasinsights.com/research-methodology/) published on this site.

## How large is the installed base of automated medication dispensing cabinets in 2025?

About 418,000 automated medication dispensing cabinet-equivalents are installed worldwide in 2025, Douglas Insights counts, with roughly 151,000 of them in US hospitals. The figure comes from staffed beds per cabinet, survey adoption rates and disclosed recall fleets, and it sets the replacement pool that drives most shipments.

The US anchor is firm. The [American Hospital Association fast facts page](https://www.aha.org/statistics/fast-facts-us-hospitals) lists 6,100 US hospitals and 907,216 staffed beds from the 2024 AHA Annual Survey. At one cabinet-equivalent per 6.0 staffed beds, a ratio typical of profiled medical-surgical wards, that bed count supports about 151,200 units. The ASHP national survey of 1,437 general and children's hospitals found 74.5% using automated dispensing cabinets as their primary distribution method, so the US fleet is mature rather than new.

Outside the US, Douglas Insights puts the base near 267,000 cabinet-equivalents, weighted toward Western Europe, Japan, Australia and the Gulf. A nine-year service life turns 418,000 installed units into about 46,400 replacements a year. Net new placements add roughly 6,200, giving the 52,600 shipments in the receipt.

## Which cabinet type makes the money in automated medication dispensing: main drawer units, towers, safes or countertop stations?

Main drawer cabinets carry 46.7% of 2025 automated medication dispensing cabinet revenue, worth USD 1.09 billion, because every ward installation starts with a console and drawer base. Countertop and anaesthesia workstations are the fastest segment at 8.69% a year, lifted by operating rooms and surgery centres.

| Segment | Share 2025 | Value 2025 | Growth 2026-2035 | Value 2035 |
| --- | --- | --- | --- | --- |
| Main drawer cabinets | 46.7% | USD 1.09 billion | 5.21% | USD 1.81 billion |
| Auxiliary and tower cabinets | 24.3% | USD 566.2 million | 5.86% | USD 1.00 billion |
| Controlled substance safes | 15.8% | USD 368.2 million | 6.58% | USD 696.4 million |
| Countertop and anaesthesia workstations | 13.2% | USD 307.6 million | 8.69% | USD 707.8 million |

Main drawer cabinets, at USD 1.09 billion, hold the console, the biometric login and the matrix or cubie drawers that most doses leave from. Their 5.21% growth tracks replacement cycles more than new wards.

Auxiliary and tower cabinets add USD 566.2 million. Towers hold bulk fluids, larger kits and refrigerated items next to the main unit, and they grow at 5.86% as hospitals widen par levels.

Controlled substance safes are worth USD 368.2 million and grow at 6.58%. Their share of 15.8% reflects the separate locked, single-access pockets that opioid diversion programmes require.

Countertop and anaesthesia workstations bring in USD 307.6 million, the smallest share at 13.2%. They expand fastest, at 8.69%, because surgery centres, procedure rooms and long-term care sites buy compact units rather than full consoles, reaching USD 707.8 million by 2035.

## Why are hospitals still buying automated medication dispensing cabinets when most wards already have one?

Unit volume grows 4.1% a year to 2035, and three forces explain all of it: a replacement wave adds 1.7 points, non-acute sites add 1.3 points and nurse workflow and diversion control add 1.1 points. Together they lift automated medication dispensing cabinet shipments from 52,600 to 78,613 units.

Replacement is the largest leg, at 1.7 points. Douglas Insights assumes cabinets installed in the 2014 to 2018 upgrade wave reach the end of a nine-year life between 2025 and 2030. BD launched the BD Incada Connected Care Platform with its next-generation Pyxis Pro solution in the results it released on 6 November 2025, as its [fiscal 2025 results filing](https://www.sec.gov/Archives/edgar/data/10795/000162828025049835/ex99109302025.htm) shows, and Omnicell debuted Titan XT at the December 2025 ASHP Midyear meeting, per its [fiscal 2025 results release](https://ir.omnicell.com/news/news-details/2026/Omnicell-Announces-Fiscal-Year-and-Fourth-Quarter-2025-Financial-Results). Two new flagship platforms in one quarter give hospitals a reason to retire 2016-era consoles rather than patch them. Douglas Insights calculates that 46,400 of the 52,600 cabinets shipped in 2025, or 88.2%, replaced an older unit, and that share stays above 80% until 2031, when the 2025 to 2027 Titan XT and Pyxis Pro installations start their own nine-year clocks.

Non-acute sites contribute 1.3 points. The US counts 6,100 hospitals, yet surgery centres, rehabilitation units and long-term care facilities hold far more medication rooms, and most still rely on locked carts. Douglas Insights models non-acute buyers rising from 11.8% of automated medication dispensing cabinet shipments in 2025 to 17.4% in 2035. Compact countertop units at USD 9,000 to 16,000 make the business case work for a 40-bed site.

Workflow and diversion control add 1.1 points. Nurses retrieve most ward doses from cabinets, and every override, discrepancy and controlled-substance count is logged by user and time. Health systems now feed those logs into diversion analytics, and each extra profiled cabinet closes a gap where a dose would otherwise move from a cart drawer without a record. Labour pressure adds weight: Omnicell's 2025 annual report cites technician deficits at 88% of hospitals, so cabinets that cut restock and count time pay back in staff hours.

The 1.7, 1.3 and 1.1 point contributions sum to the 4.1% volume leg. Price adds 1.9% a year as cloud software, RFID bins and biometric readers lift the average realised USD 44,300 per cabinet to USD 53,474 by 2035.

## What limits automated medication dispensing cabinet shipments: recalls, capital budgets or cheaper locked carts?

Three restraints together remove 1.5 points from automated medication dispensing cabinet volume growth in the slower case: capital deferral 0.7 points, firmware and recall risk 0.3 points and low-cost substitutes 0.5 points. They would pull 2035 revenue down to USD 3.39 billion.

Capital deferral is the heaviest drag, at 0.7 points. A full ward refresh at a 400-bed hospital runs to about 67 cabinet-equivalents, or near USD 2.97 million at the 2025 average price, and capital committees often push such projects back a budget year. BD's international medication management revenue fell 1.0% in fiscal 2025 to USD 664 million, a sign that ex-US buyers are delaying.

Firmware and recall risk removes 0.3 points. The 20 November 2025 Pyxis action covered 53,669 units after a firmware update produced duplicate drawer addresses and drawer failures, as the [FDA Class 2 recall notice](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=216381) records, and hospitals had to fall back on manual access procedures until firmware 1.49 arrived. Each such event slows purchase approvals while safety teams review downtime plans.

Low-cost substitutes take 0.5 points. Smart carts with keypad drawers, RFID kits and pharmacy-filled unit-dose trays cost a fraction of a USD 44,300 cabinet, and smaller hospitals in Latin America and Africa often choose them first.

## How much does a hospital pay for an automated medication dispensing cabinet console, tower or safe?

A main automated medication dispensing cabinet with console sells for about USD 38,000 to 62,000 in 2025, Douglas Insights estimates. Towers fetch USD 14,000 to 24,000 and controlled substance safes USD 21,000 to 35,000. The blended realised price is USD 44,300 per cabinet-equivalent.

Countertop units sit lowest, at USD 9,000 to 16,000, while anaesthesia workstations with weighing bins reach USD 30,000 to 45,000. Annual software, support and cloud fees add about 11% to 15% of capital each year, and those service fees sit outside this sizing.

Public tenders show the per-cabinet scale for smaller sites. NHS Leeds awarded TouchPoint Medical a five-year automated dispensing cabinet contract worth GBP 111,600 on 10 September 2025, running from 28 November 2025 to 27 November 2030, according to the [UK Contracts Finder notice](https://www.contractsfinder.service.gov.uk/Notice/e6f116f1-330c-46ae-bdf4-8c0847c4122f).

Price rises 1.9% a year in the base case. RFID-tagged bins, biometric login and cloud consoles add value, while competitive bids from Capsa and TouchPoint hold the low end down.

## Which companies supply automated medication dispensing cabinets, and how concentrated is the Pyxis and Omnicell duopoly?

BD holds an estimated 49.1% share of 2025 automated medication dispensing cabinet revenue, about USD 1.14 billion, and the top three suppliers hold 72.2%. Douglas Insights estimates these shares from disclosed segment revenues; neither BD nor Omnicell reports cabinet revenue on its own.

| Company | Flagship cabinet line | Estimated 2025 share | Estimated 2025 cabinet revenue |
| --- | --- | --- | --- |
| BD | Pyxis MedStation ES and Pyxis Pro | 49.1% | USD 1.14 billion |
| Omnicell | XT Series and Titan XT | 18.4% | USD 428.8 million |
| Swisslog Healthcare | MedSMART | 4.7% | USD 109.5 million |
| Capsa Healthcare | NexsysADC | 3.9% | USD 90.9 million |
| TouchPoint Medical | MedDispense | 2.8% | USD 65.2 million |
| Advantech | AMiS-870 | 1.6% | USD 37.3 million |

BD's position rests on the Pyxis fleet and its medication management unit, which earned USD 3.47 billion in fiscal 2025, up 5.4%, with USD 2.81 billion from the US, as its [SEC results exhibit](https://www.sec.gov/Archives/edgar/data/10795/000162828025049835/ex99109302025.htm) shows. Infusion pumps share that line, so cabinet revenue is roughly one third of it.

Omnicell is the clear second. Its 2025 product revenue was USD 665.7 million within total revenue of USD 1.19 billion, and about 90% of revenue came from the US, per its [investor release](https://ir.omnicell.com/news/news-details/2026/Omnicell-Announces-Fiscal-Year-and-Fourth-Quarter-2025-Financial-Results) and annual report. The XT Series with XTExtend console swaps and the new Titan XT keep it in every large US tender.

Swisslog Healthcare sells MedSMART cabinets in Europe through a TriaTech Medical Systems partnership announced in 2022. Capsa Healthcare launched NexsysADC in 2018 for extended care, surgery centres and clinics. TouchPoint Medical wins NHS work with MedDispense, and Advantech offers the AMiS-870 cabinet with RFID-enabled bins and medTRx software.

The 20 November 2025 recall is a test of BD's lead. Douglas Insights expects BD to keep above 45% share through 2030 because a recall fixed by firmware rarely triggers a vendor switch, but rivals now cite downtime planning in every bid. Compare the vendor field in our [Hospital Pharmacy Automation Market](https://www.douglasinsights.com/hospital-pharmacy-automation-market/) study and the robot makers in the [Healthcare Robotics Market](https://www.douglasinsights.com/healthcare-robotics-market/) report.

## Where do automated medication dispensing cabinet sales grow fastest, North America or Asia Pacific?

North America leads with USD 1.22 billion of 2025 automated medication dispensing cabinet revenue, but Asia Pacific grows fastest, at 8.46% a year to USD 923.8 million in 2035. New tertiary hospitals in China, India and Southeast Asia are buying ward cabinets for the first time.

North America's USD 1.22 billion grows at 5.18%, the replacement-led pace of a fleet where 74.5% of surveyed hospitals already rely on cabinets. The US alone holds most of the 151,000-unit hospital base.

Europe adds USD 515.0 million at 5.62%. Germany, France, the UK and the Nordics are moving from ward cupboards to cabinets, and NHS framework call-offs such as the Leeds award set the pace.

Asia Pacific starts at USD 410.1 million. Japan and Australia are mature buyers, while greenfield hospitals elsewhere install profiled cabinets from day one, which explains the 8.46% rate.

Latin America is worth USD 100.2 million and grows 7.12%, led by private hospital groups in Brazil and Mexico. The Middle East and Africa, at USD 83.9 million and 7.17%, is the wildcard: Gulf hospital programmes buy at US specifications, while much of Africa still uses locked carts.

## Can automated medication dispensing cabinets move beyond the acute ward into long-term care and surgery centres?

Non-acute sites take 11.8% of automated medication dispensing cabinet shipments in 2025, about 6,200 units, and Douglas Insights models 17.4% by 2035. Long-term care pharmacies, surgery centres and urgent care clinics want controlled-substance tracking without a full hospital console, at a fraction of its price.

In the US, the Drug Enforcement Administration (DEA) lets retail pharmacies run automated dispensing systems inside long-term care facilities under a separate registration at each site, as [21 CFR 1301.27](https://www.ecfr.gov/current/title-21/chapter-II/part-1301/subject-group-ECFR6f1c3da0a6f1f19/section-1301.27) sets out. Each registration ties one pharmacy to one facility, so pharmacy chains that serve 50 homes place 50 cabinets. Readers tracking unit-dose supply should also see our [Pharmacy Repackaging Systems Market](https://www.douglasinsights.com/pharmacy-repackaging-systems-market/) report.

Compact cabinets fit these sites. A 4-drawer countertop unit at USD 9,000 to 16,000 covers a 40-bed home, against USD 38,000 or more for a ward console.

## How do automated medication dispensing cabinets reduce nurse retrieval time and opioid diversion?

Automated medication dispensing cabinets log 100% of controlled-substance removals by user, time and patient, Douglas Insights notes, which is why diversion teams treat them as the primary audit trail. Retrieval sits on the ward, so nurses skip pharmacy trips for first doses.

Profiled cabinets release only doses on a pharmacist-verified order; override lists cover emergencies. More than 80% of surveyed hospitals scan barcodes when restocking cabinets, which cuts wrong-drug loading. Blind counts, witness logins and discrepancy alerts make the 15.8% safe segment the backbone of opioid control.

## Which DEA and CMS rules govern controlled-substance storage in automated medication dispensing cabinets?

Automated medication dispensing cabinet design in the US answers to 2 rule sets. They are Drug Enforcement Administration registration rules under 21 CFR Part 1301 and the [Centers for Medicare](https://www.cms.gov/) and Medicaid Services (CMS) hospital pharmacy condition at 42 CFR 482.25. Together they govern a market worth USD 1.22 billion in North America.

Under [the DEA rule for long-term care automated dispensing systems](https://www.ecfr.gov/current/title-21/chapter-II/part-1301/subject-group-ECFR6f1c3da0a6f1f19/section-1301.27), only a registered retail pharmacy can install and operate an automated dispensing system at a long-term care facility, with fee-exempt extra registrations. For hospitals, 42 CFR 482.25 requires Schedule II to V drugs to be kept locked within a secure area, with current records of receipt and disposition, and any loss reported at once to the pharmacy director and chief executive. Cabinets with blind counts and user logs meet those 2 duties by design.

Medical device rules apply too. The US Food and Drug Administration ([FDA](https://www.fda.gov/)) classified the Pyxis firmware action as Class 2 on 19 December 2025, with design named as the cause, so suppliers now document firmware validation in tenders, per the [FDA recall record](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=216381).

## What would a faster Pyxis and XT replacement cycle do to the 2035 automated medication dispensing cabinet forecast?

A faster replacement cycle lifts the 2035 automated medication dispensing cabinet market to USD 5.00 billion, against USD 4.20 billion in the base case and USD 3.39 billion in the slower case. Volume grows 5.4%, 4.1% or 2.6% a year across the three cases.

The base case combines 4.1% volume and 1.9% price growth, giving 6.08% a year. The faster case, at 5.4% volume and 2.4% price, assumes Titan XT and Pyxis Pro pull refreshes forward by two years. The slower case, at 2.6% volume and 1.2% price, assumes capital freezes and recall caution after the 20 November 2025 event.

Sensitivity is high. A 1-point shift in annual volume growth changes the 2035 value by about USD 422 million, roughly 10% of the base figure. Published forecasts run from about 5.5% to 7.2% a year, and our 6.08% lies close to their middle.

## Douglas Exclusive: the ADC Replacement-Readiness Scorecard

The ADC Replacement-Readiness Scorecard is a Douglas Insights model built from 16 inputs. Those are 11 sourced figures (AHA hospitals and beds, the ASHP adoption rate and sample, the 53,669-unit recall fleet, BD US and international revenue, Omnicell product revenue and US share, the NHS Leeds award and the DEA rule) plus our five regional models.

Each region scores 1 to 5 on four tests: fleet age, ward coverage gap, controlled-substance rule pressure and capital access. The weighted total, out of 20, shows where automated medication dispensing cabinet shipments arrive soonest.

| Region | Fleet age | Coverage gap | Rule pressure | Capital access | Score of 20 |
| --- | --- | --- | --- | --- | --- |
| North America | 5 | 1 | 5 | 4 | 15 |
| Europe | 4 | 3 | 3 | 3 | 13 |
| Asia Pacific | 2 | 5 | 2 | 4 | 13 |
| Latin America | 2 | 4 | 2 | 2 | 10 |
| Middle East and Africa | 1 | 4 | 2 | 2 | 9 |

The finding: North America scores 15 of 20 on replacement, not coverage, so its USD 1.22 billion grows on refresh alone. Europe and Asia Pacific tie at 13 for different reasons, which is why Asia Pacific's 8.46% rate tops Europe's 5.62%.

## Methodology check: do 52,600 automated medication dispensing cabinet shipments really add up to USD 2.33 billion?

Yes: 52,600 cabinet-equivalents times USD 44,300 equals USD 2.33 billion, and Douglas Insights cross-checks that total against BD and Omnicell disclosures and the 907,216-bed US hospital base. The model covers 31 countries in five regions and uses 11 sourced data points, each traced to a filing, regulator or survey.

Cross-check one: BD's estimated USD 1.14 billion cabinet revenue is 32.9% of its USD 3.47 billion medication management line. Omnicell's USD 428.8 million is 64.4% of its USD 665.7 million product revenue. Together they equal 67.5% of the market, against a 72.2% top-three share once Swisslog is added.

Cross-check two: 418,000 installed units divided by a nine-year life gives 46,400 replacements, plus 6,200 non-acute and greenfield units, matching 52,600 shipments. Cross-check three: the US hospital base of 151,200 units implied by 907,216 beds accounts for about 36% of the 418,000-unit global fleet, in line with North America holding 52.4% of revenue at higher US prices.

## Market by segment

| Segment | Share | Value |
| --- | --- | --- |
| Main drawer cabinets | 46.7% | $1.09 Bn |
| Auxiliary and tower cabinets | 24.3% | $566.2 Mn |
| Controlled substance safes | 15.8% | $368.2 Mn |
| Countertop and anaesthesia workstations | 13.2% | $307.6 Mn |

## Market by region (USD million)

| Region | 2025 | 2026 | 2035 | CAGR 2026-2035 |
| --- | --- | --- | --- | --- |
| Global | 2,330.18 | 2,471.9 | 4,203.8 | 6.08% |
| North America | 1,221 | 1,284.2 | 2,023.2 | 5.18% |
| Europe | 515 | 543.9 | 889.8 | 5.62% |
| Asia Pacific | 410.1 | 444.8 | 923.8 | 8.46% |
| Latin America | 100.2 | 107.3 | 199.3 | 7.12% |
| Middle East and Africa | 83.9 | 89.9 | 167.7 | 7.17% |

## Dataset

| Series | Value | Unit |
| --- | --- | --- |
| Market size 2025 | 2,330.18 | USD million |
| Market size 2035 | 4,203.8 | USD million |
| Revenue CAGR 2026-2035 | 6.08 | percent |
| Volume CAGR 2026-2035 | 4.1 | percent |
| Price per cabinet CAGR 2026-2035 | 1.9 | percent |

## Frequently asked questions

### How many automated medication dispensing cabinets are installed worldwide?

About 418,000 cabinet-equivalents in 2025, Douglas Insights counts, including roughly 151,000 in US hospitals, based on 907,216 staffed beds at one cabinet per 6.0 beds.

### What is the automated medication dispensing cabinet market worth in 2025 and 2035?

USD 2.33 billion in 2025, from 52,600 cabinet-equivalents at USD 44,300 each, rising to USD 4.20 billion by 2035 at 6.08% a year.

### Why do hospitals that already own cabinets keep buying them?

1.7 points of the 4.1% volume growth come from replacement, as cabinets reach the end of a nine-year life and BD and Omnicell launch Pyxis Pro and Titan XT.

### What happened with the BD Pyxis recall in November 2025?

53,669 units were covered by a Class 2 recall initiated on 20 November 2025 after a firmware update caused drawer failures; firmware 1.49 fixes it.

### How much does a main ward cabinet sell for?

USD 38,000 to 62,000 for a main cabinet with console in 2025, Douglas Insights estimates, against USD 9,000 to 16,000 for a countertop unit.

### Who leads automated dispensing cabinet supply?

49.1% of 2025 revenue goes to BD by Douglas Insights estimate, with Omnicell at 18.4% and the top three at 72.2%.

### Which cabinet format is expanding quickest?

8.69% a year for countertop and anaesthesia workstations, as surgery centres and long-term care pharmacies buy compact units; the segment reaches USD 707.8 million by 2035.

### What does the DEA require for cabinets in nursing homes?

1 separate DEA registration per long-term care facility under 21 CFR 1301.27, held by a retail pharmacy, which alone may install and run the system.

## Sources

- [US Food and Drug Administration, BD Pyxis MedStation Class 2 recall](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=216381)
- [SEC EDGAR / BD, BD fourth quarter and fiscal 2025 results (Exhibit 99.1)](https://www.sec.gov/Archives/edgar/data/10795/000162828025049835/ex99109302025.htm)
- [Omnicell, Omnicell fiscal year and fourth quarter 2025 results](https://ir.omnicell.com/news/news-details/2026/Omnicell-Announces-Fiscal-Year-and-Fourth-Quarter-2025-Financial-Results)
- [SEC EDGAR, Omnicell Form 10-K for 2025](https://www.sec.gov/Archives/edgar/data/926326/000092632626000006/omcl-20251231.htm)
- [eCFR, 21 CFR 1301.27](https://www.ecfr.gov/current/title-21/chapter-II/part-1301/subject-group-ECFR6f1c3da0a6f1f19/section-1301.27)
- [American Hospital Association, Fast Facts on U.S. Hospitals, 2026](https://www.aha.org/statistics/fast-facts-us-hospitals)
- [UK Contracts Finder, Automated Dispensing Cabinet (Medicine Robots) award](https://www.contractsfinder.service.gov.uk/Notice/e6f116f1-330c-46ae-bdf4-8c0847c4122f)
- [American Journal of Health-System Pharmacy, ASHP national survey of pharmacy practice in hospital settings: dispensing and administration, 2020](https://experts.arizona.edu/en/publications/ashp-national-survey-of-pharmacy-practice-in-hospital-settings-di-7/)

## How to cite

Douglas Insights, "Automated Medication Dispensing Cabinet Market", DI-HC-10491, updated 2026-10-07, https://www.douglasinsights.com/automated-medication-dispensing-cabinet-market/